Publicaciones (44) Publicaciones en las que ha participado algún/a investigador/a

2022

  1. A linear-polymer-based lactoferrin-selective recognition element for an ELISA mimic: A proof of concept

    Analytica Chimica Acta, Vol. 1191

  2. Analysis of Mitochondrial Function in Cell Membranes as Indicator of Tissue Vulnerability to Drugs in Humans

    Biomedicines, Vol. 10, Núm. 5

  3. Application of physiologically based absorption and pharmacokinetic modeling in the development process of oral modified release generic products

    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, Vol. 176, pp. 87-94

  4. Cannabinoid Receptors and Glial Response Following a Basal Forebrain Cholinergic Lesion

    ACS Pharmacology and Translational Science, Vol. 5, Núm. 9, pp. 791-802

  5. Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams-Beuren syndrome

    eLife, Vol. 11

  6. Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients

    Addiction Biology, Vol. 27, Núm. 6

  7. Conformational Rearrangements Regulating the DNA Repair Protein APE1

    International Journal of Molecular Sciences, Vol. 23, Núm. 14

  8. Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB1 receptor density in cell membranes: an alternative to radioligand binding methods

    Microbial Cell Factories, Vol. 21, Núm. 1

  9. Dopamine D4 receptor is a regulator of morphine-induced plasticity in the rat dorsal striatum

    Cells, Vol. 11, Núm. 1

  10. Dose-Dependent Antidepressant-Like Effects of Cannabidiol in Aged Rats

    Frontiers in Pharmacology, Vol. 13

  11. Dual effect of TAT functionalized DHAH lipid nanoparticles with neurotrophic factors in human BBB and microglia cultures

    Fluids and Barriers of the CNS, Vol. 19, Núm. 1

  12. Elevation of Tear MMP-9 Concentration as a Biomarker of Inflammation in Ocular Pathology by Antibody Microarray Immunodetection Assays

    International Journal of Molecular Sciences, Vol. 23, Núm. 10

  13. Exploring pharmacological options for adolescent depression: a preclinical evaluation with a sex perspective

    Translational Psychiatry, Vol. 12, Núm. 1

  14. Farmako antipsikotikoak eta aho-patologia: eragin kaltegarriak jakinarazteko Europako sistemaren bidezko analisia

    Osagaiz: osasun-zientzien aldizkaria, Vol. 6, Núm. 1, pp. 55-66

  15. Farmakologia Aplikatua: oinarri teorikoak medikamentuak zentzuz erabiltzeko

    Osagaiz: osasun-zientzien aldizkaria, Vol. 6, Núm. 1, pp. 135-136

  16. Functional characterization of cannabidiol effect on the serotonergic neurons of the dorsal raphe nucleus in rat brain slices

    Frontiers in Pharmacology, Vol. 13

  17. Fundamental Insights into Free-Radical Polymerization in the Presence of Catechols and Catechol-Functionalized Monomers

    Macromolecules, Vol. 55, Núm. 1, pp. 49-64

  18. Glucocorticoid receptor dysregulation underlies 5-HT2AR-dependent synaptic and behavioral deficits in a mouse neurodevelopmental disorder model

    Journal of Biological Chemistry, Vol. 298, Núm. 11

  19. Glutamate, Glutamatergic Drugs and Schizophrenia

    Glutamate and Neuropsychiatric Disorders: Current and Emerging Treatments (Springer International Publishing), pp. 493-521

  20. Handling and novel object recognition modulate fear response and endocannabinoid signaling in nucleus basalis magnocellularis

    European Journal of Neuroscience, Vol. 55, Núm. 6, pp. 1532-1546